Haemonetics HAE
NYSE HAE
$100.79 -2.37 (-2.29%)
As of: Sep 10, 2026 · 3:25 PM EDT

Haemonetics (HAE) Share-based Compensation Growth (5y) (2014 - 2026)

Analysis

Haemonetics (HAE) Share-based Compensation Growth (5y) (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 180.08 Bn 174.48 Bn 7.27 Bn
2 Intuitive Surgical 127.86 Bn 122.64 Bn 1.96 Bn
3 Medtronic 117.15 Bn 108.33 Bn 6.34 Bn
4 Stryker 103.82 Bn 100.34 Bn 4.50 Bn
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn
6 Edwards Lifesciences 49.76 Bn 45.51 Bn 1.35 Bn
7 Alcon 32.95 Bn 31.49 Bn 1.68 Bn
8 Dexcom 32.22 Bn 30.27 Bn 830.00 Mn
9 Steris 20.71 Bn 20.23 Bn 684.20 Mn
10 Haemonetics 4.58 Bn 4.36 Bn 202.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 6.40%
Mar 28, 2026 5.12%
Dec 27, 2025 4.40%
Sep 27, 2025 4.98%
Jun 28, 2025 8.59%
Mar 29, 2025 5.14%
Dec 28, 2024 9.06%
Sep 28, 2024 -1.08%
Jun 29, 2024 15.57%
Mar 30, 2024 10.79%
Dec 30, 2023 8.58%
Sep 30, 2023 7.91%
Jul 1, 2023 15.64%
Apr 1, 2023 4.50%
Dec 31, 2022 18.83%
Oct 1, 2022 14.96%
Jul 2, 2022 31.59%
Apr 2, 2022 14.93%
Jan 1, 2022 22.16%
Oct 2, 2021 20.08%